Ardelyx reported $120.12M in Operating Expenses for its fiscal quarter ending in December of 2025.





Operating Expenses Change Date
Abbott USD 9.31B 104M Mar/2026
Amgen USD 4.78B 1.12B Mar/2026
Ardelyx USD 120.12M 14.46M Dec/2025
aTyr Pharma USD 85.61M 58.67M Dec/2025
Corcept Therapeutics USD 214.5M 16.87M Mar/2026
Curis USD 9.02M 23.01M Dec/2025
Sanofi EUR 10.71B 1.32B Dec/2025
TG Therapeutics USD 170.12M 28.04M Mar/2026
United Therapeutics USD 5.9B 5.1B Mar/2026
Xoma USD 22.84M 1.67M Sep/2024